PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer

Figure 6

Survival analysis of PCMT1 in breast cancer, including OS, RFS, DMFS, and PPS.

(a)

(b)

(c)

(d)